Linked Life Data

15960649

Source:http://linkedlifedata.com/resource/pubmed/id/15960649

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2005-6-17
pubmed:abstractText
Dexmedetomidine is a centrally acting alpha-2 adrenergic agonist that is currently approved by the US Food and Drug Administration for short-term use (< or = 24 h) to provide sedation in adults in the ICU. This drug has been shown to be efficacious in adult medical and surgical patients in providing sedation, anxiolysis, and analgesia. Dexmedetomidine has been associated with rapid onset and offset, hemodynamic stability, and a natural, sleep-like state in mechanically ventilated adults. To date, there are few publications of the use of this drug in children, and prolonged infusion has not been described. We report our use of dexmedetomidine in a child during a 4-day period of mechanical ventilation following tracheal reconstruction for subglottic stenosis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1155-5645
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
616-20
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Prolonged infusion of dexmedetomidine for sedation following tracheal resection.
pubmed:affiliation
Department of Anesthesia, Stanford University School of Medicine, Lucile Packard Children's Hospital, Stanford, CA 94305-5640, USA. ham@stanford.edu
pubmed:publicationType
Journal Article, Case Reports